Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

2,604 public trials 547 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Completed

Etoposide in Treating Patients With Relapsed Non-Hodgkin's Lymphoma

NCT00002880

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +27 more
Locations
  • University of Minnesota Cancer Center Minneapolis, Minnesota, United States
  • Washington University Barnard Cancer Center St Louis, Missouri, United States
  • St. Joseph's Hospital and Medical Center Paterson, New Jersey, United States
  • Comprehensive Cancer Center of Wake Forest University Baptist Medical Center Winston-Salem, North Carolina, United States
View Trial Details
Completed

Aurora A Kinase Inhibitor MLN8237 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma

NCT01034553

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • University of California, San Francisco San Francisco, California, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Completed

Bendamustine, Bortezomib (Velcade ®) and Prednisone (BVP) in Patients Newly Diagnosed Multiple Myeloma

NCT01376401

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Hospital Germans Trias i Pujol Badalona, Barcelona, Spain
  • Hospital Clínic Barcelona, Spain
  • Institut català d'Oncología Barcelona, Spain
  • Hospital 12 de Octubre Madrid, Spain
View all 14 locations
View Trial Details

Related conditions